全文获取类型
收费全文 | 628篇 |
免费 | 35篇 |
国内免费 | 6篇 |
专业分类
耳鼻咽喉 | 8篇 |
儿科学 | 26篇 |
妇产科学 | 8篇 |
基础医学 | 103篇 |
口腔科学 | 21篇 |
临床医学 | 63篇 |
内科学 | 171篇 |
皮肤病学 | 5篇 |
神经病学 | 50篇 |
特种医学 | 13篇 |
外科学 | 32篇 |
综合类 | 10篇 |
预防医学 | 35篇 |
眼科学 | 25篇 |
药学 | 49篇 |
中国医学 | 6篇 |
肿瘤学 | 44篇 |
出版年
2023年 | 10篇 |
2022年 | 21篇 |
2021年 | 32篇 |
2020年 | 8篇 |
2019年 | 21篇 |
2018年 | 15篇 |
2017年 | 15篇 |
2016年 | 23篇 |
2015年 | 29篇 |
2014年 | 25篇 |
2013年 | 37篇 |
2012年 | 44篇 |
2011年 | 44篇 |
2010年 | 32篇 |
2009年 | 31篇 |
2008年 | 33篇 |
2007年 | 32篇 |
2006年 | 33篇 |
2005年 | 33篇 |
2004年 | 34篇 |
2003年 | 21篇 |
2002年 | 20篇 |
2001年 | 5篇 |
2000年 | 1篇 |
1999年 | 9篇 |
1998年 | 5篇 |
1997年 | 4篇 |
1996年 | 10篇 |
1994年 | 4篇 |
1993年 | 1篇 |
1992年 | 1篇 |
1991年 | 2篇 |
1990年 | 2篇 |
1989年 | 3篇 |
1988年 | 3篇 |
1987年 | 5篇 |
1986年 | 5篇 |
1985年 | 4篇 |
1982年 | 5篇 |
1980年 | 2篇 |
1979年 | 1篇 |
1978年 | 2篇 |
1976年 | 1篇 |
1970年 | 1篇 |
排序方式: 共有669条查询结果,搜索用时 15 毫秒
661.
662.
Ramatu Wuni Nagarajan Lakshmipriya Kuzhandaivelu Abirami Eduard Flores Ventura Ranjit Mohan Anjana Vasudevan Sudha Shanmugam Shobana Ranjit Unnikrishnan Kamala Krishnaswamy Karani Santhanakrishnan Vimaleswaran Viswanathan Mohan 《Nutrients》2022,14(18)
There is conflicting evidence about the association between dairy products and cardiometabolic risk (CMR). We aimed to assess the association of total dairy intake with CMR factors and to investigate the association of unfermented and fermented dairy intake with CMR in Asian Indians who are known to have greater susceptibility to type 2 diabetes and cardiovascular diseases compared to white Europeans. The study comprised 1033 Asian Indian adults with normal glucose tolerance chosen from the Chennai Urban Rural Epidemiological Study (CURES). Dietary intake was assessed using a validated open-ended semi-quantitative food frequency questionnaire. Metabolic syndrome (MS) was diagnosed based on the new harmonising criteria using central obesity, dyslipidaemia [low high-density lipoprotein cholesterol (HDL) and increased serum triglycerides (TG)], hypertension and glucose intolerance. Increased consumption of dairy (≥5 cups per day of total, ≥4 cups per day of unfermented or ≥2 cups per day of fermented dairy) was associated with a lower risk of high fasting plasma glucose (FPG) [hazards ratio (HR), 95% confidence interval (CI): 0.68, 0.48–0.96 for total dairy; 0.57, 0.34–0.94 for unfermented dairy; and 0.64, 0.46–0.90 for fermented dairy; p < 0.05 for all] compared to a low dairy intake (≤1.4 cups per day of total dairy; ≤1 cup per day of unfermented dairy; and ≤0.1 cup per day of fermented dairy). A total dairy intake of ≥5 cups per day was also protective against high blood pressure (BP) (HR: 0.65, 95% CI: 0.43–0.99, p < 0.05), low HDL (HR: 0.63, 95% CI: 0.43–0.92, p < 0.05) and MS (HR: 0.71, 95% CI: 0.51–0.98, p < 0.05) compared to an intake of ≤1.4 cups per day. A high unfermented dairy intake (≥4 cups per day) was also associated with a lower risk of high body mass index (BMI) (HR: 0.52, 95% CI: 0.31–0.88, p < 0.05) compared to a low intake (≤1 cup per day), while a reduced risk of MS was observed with a fermented dairy intake of ≥2 cups per day (HR: 0.71, 95% CI: 0.51–0.98, p < 0.05) compared to an intake of ≤0.1 cup per day. In summary, increased consumption of dairy was associated with a lower risk of MS and components of CMR. 相似文献
663.
Jothydev Kesavadev Anjana Basanth Gopika Krishnan Rebecca Vitale Hari Parameswaran Sajna Shijin Sreelakshmi R Sumesh Raj Asha Ashik Arun Shankar Sameer Badarudeen A.V. Raveendran Indu Rajalakshmy Geethu Sanal Akhila Manoj Remya Jose Yaseen Unes Sunitha Jothydev 《Diabetes & Metabolic Syndrome: Clinical Research & Reviews》2021,15(5):102228
AimAmidst COVID-19 pandemic, the health care delivery in India faces major challenges owing to the overwhelming hospitals, exhausted healthcare workers, and shortage of crucial medical supplies such as ventilators and oxygen. The study aims to propose a novel successful interventional home care model, the Virtual COVID In-Patient (VCIP) care for effective COVID management.MethodsThe Covid-19 positive patients enrolled in VCIP were chosen for the study. A 24/7 active multidisciplinary WhatsApp group was created for each patient, for remote monitoring of temperature, blood pressure, blood glucose, respiratory and pulse rate along with the symptoms. Advice on sleep and exercises were given along with the medication via video-audio consultations. Lab facility was provided at the doorstep. Training on various devices, medications including steroids, delivering subcutaneous injections etc were given via video platforms.ResultsAmong the 220 patients who availed the VCIP facility, only two were hospitalized, yielding a 99.5 % success rate in preventing hospitalizations and patients enrolled have been immensely satisfied with their experience.ConclusionsWith similar pandemics anticipated in near future, VCIP model may be considered for successful domiciliary treatment and overcoming the challenges. 相似文献
664.
Noor Fishan Kurt Towers Javier Haurat Anthony Zimmermann Anjana Radhakutty 《Internal medicine journal》2023,53(10):1916-1918
Sodium–glucose co-transporter-2 inhibitors (SGLT2i) have renal and cardiovascular benefits in addition to their glucose-lowering potential. Data on the efficacy and safety of SGLT2i in Australian Aboriginal and Torres-Strait Islanders are lacking. We conducted a single-centre retrospective study assessing the safety and effects on glycaemic control and albuminuria of SGLT2i in Aboriginal and Torres Strait Islander patients with type 2 diabetes mellitus. 相似文献
665.
666.
V Sidheeque Hassan Mohd Hanifa Umashanker Navik Anjana Bali 《Fundamental & clinical pharmacology》2023,37(3):607-617
Sepsis-induced myocardial injury is a consequence of septicemia and is one of the major causes of death in intensive care units. A serum glycoprotein called fetuin-A is secreted largely by the liver, tongue, placenta, and adipose tissue. Fetuin-A has a variety of biological and pharmacological properties. The anti-inflammatory and antioxidant glycoprotein fetuin-A has shown its efficacy in a number of inflammatory disorders including sepsis. However, its protective role against sepsis-induced myocardial injury remains elusive. The purpose of this work is to explore the role of fetuin-A in mouse models of myocardial injury brought on by cecal ligation and puncture (CLP). CLP significantly induced the myocardial injury assessed in terms of elevated myocardial markers (serum CK-MB, cTnI levels), inflammatory markers (IL-6, TNF-α) in the serum, and oxidative stress markers (increased MDA levels and decreased reduced glutathione) in heart tissue homogenate following 24 h of ligation and puncture. Further, hematoxylin and eosin (H&E) staining showed considerable histological alterations in the myocardial tissue of sepsis-developed mice. Interestingly, fetuin-A pretreatment (50 and 100 mg/kg) for 4 days before the CLP procedure significantly improved the myocardial injury and was evaluated in perspective of a reduction in the CK-MB, cTnI levels, IL-6, and TNF-α in sepsis-developed animals. Fetuin-A pretreatment significantly attenuated the oxidative stress and improved the myocardial morphology in a dose-dependent manner. The present study provides preliminary evidence that fetuin-A exerts protection against sepsis-induced cardiac dysfunction in vivo via suppression of inflammation and oxidative damage. 相似文献
667.
668.
669.